Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd announced the issuance of 7,179,233 unquoted equity securities, specifically options expiring on February 29, 2028, with an exercise price of $0.75. This move is part of the company’s strategic financial operations, potentially impacting its market positioning by enhancing its capital structure and providing opportunities for future growth and investment.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company is known for its advanced respiratory imaging products, which aim to improve patient outcomes and provide detailed insights into lung function.
Average Trading Volume: 4,370,389
Technical Sentiment Signal: Buy
Current Market Cap: A$1.08B
See more insights into 4DX stock on TipRanks’ Stock Analysis page.